News
1d
Pharmaceutical Technology on MSNFDA approves Capsida’s CAP-003 gene therapy for Parkinson’s"FDA approves Capsida’s CAP-003 gene therapy for Parkinson’s" was originally created and published by Pharmaceutical ...
Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and ...
Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary ...
Gene therapy experts and advocates warning of the sector’s many challenges found a receptive audience in FDA leadership at a ...
Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases ...
SpliceBio's lead in-house pipeline project is in Stargardt disease, an IRD with no approved therapies that is caused by ...
Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...
The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...
Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results